Ticagrelor market to reach $2.75 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of cardiovascular diseases worldwide.
Read More
Tibsovo market to reach $1.7 billion by 2030 at 9.3% CAGR, driven by increasing prevalence of acute myeloid leukemia among aging populations.
Read More
Omics-based clinical trials market to reach $47.78 bn by 2030 at 8.5% CAGR, driven by rising demand for personalized medicine.
Read More
Thyroid cancer drugs market to reach $2.39 billion by 2030 at 12.8% CAGR, driven by increasing incidences of thyroid cancer requiring advanced drug therapies.
Read More
The omics lab services market is projected to reach $224.14 by 2030, growing at 15.4% CAGR, driven by liquid biopsies, companion diagnostics, and biotech investments.
Read More
Thrombosis and hemostasis biomarkers market to reach $7.37 billion by 2030 at 7.3% CAGR, driven by growing demand for precise and targeted therapies.
Read More
Global Omeprazole market size is expected to reach $3.46 billion by 2030 at 6.6%, segmented as by capsule, delayed-release capsules, immediate-release capsules
Read More
Thrombophilia market to reach $26.5 billion by 2030 at 7.8% CAGR, driven by increasing prevalence of thrombophilic conditions and growing diagnostic awareness.
Read More
Throat sprays market to reach $1.31 billion by 2030 at 5.4% CAGR, driven by increasing incidences of respiratory infections linked to pollution and seasonal illnesses.
Read More
Global Oligonucleotide Synthesis market size is expected to reach $26.08 billion by 2030 at 17.1%, the oligonucleotide synthesis market set to expand with the rising prevalence of chronic diseases
Read More